home / stock / fbrx / fbrx quote
Last: | $0.51 |
---|---|
Change Percent: | 2.46% |
Open: | $0.511 |
Close: | $0.51 |
High: | $0.511 |
Low: | $0.5 |
Volume: | 2,030 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.51 | $0.511 | $0.51 | $0.511 | $0.5 | 2,030 | 07-03-2024 |
$0.5239 | $0.55 | $0.5239 | $0.5505 | $0.5239 | 10,711 | 07-02-2024 |
$0.546 | $0.53 | $0.546 | $0.578 | $0.5239 | 7,463 | 07-01-2024 |
$0.537 | $0.548 | $0.537 | $0.5789 | $0.5274 | 3,344 | 06-28-2024 |
$0.548 | $0.524 | $0.548 | $0.548 | $0.5239 | 11,759 | 06-27-2024 |
$0.48 | $0.4801 | $0.48 | $0.57 | $0.48 | 10,044 | 06-26-2024 |
$0.46 | $0.49 | $0.46 | $0.5197 | $0.4501 | 57,547 | 06-25-2024 |
$0.49 | $0.49 | $0.49 | $0.51 | $0.4887 | 19,418 | 06-24-2024 |
$0.4887 | $0.5 | $0.4887 | $0.5159 | $0.4887 | 7,619 | 06-21-2024 |
$0.5 | $0.5 | $0.5 | $0.5297 | $0.5 | 22,854 | 06-20-2024 |
$0.535 | $0.522 | $0.535 | $0.6 | $0.522 | 25,687 | 06-19-2024 |
$0.535 | $0.522 | $0.535 | $0.6 | $0.522 | 25,687 | 06-18-2024 |
$0.5164 | $0.571 | $0.5164 | $0.571 | $0.5164 | 17,701 | 06-17-2024 |
$0.559 | $0.58 | $0.559 | $0.58 | $0.54 | 9,515 | 06-14-2024 |
$0.56 | $0.56 | $0.56 | $0.59 | $0.56 | 2,399 | 06-13-2024 |
$0.57 | $0.551 | $0.57 | $0.585 | $0.55 | 14,517 | 06-12-2024 |
$0.58 | $0.6089 | $0.58 | $0.61 | $0.550001 | 6,222 | 06-11-2024 |
$0.55 | $0.564 | $0.55 | $0.62 | $0.55 | 32,671 | 06-10-2024 |
$0.5831 | $0.6 | $0.5831 | $0.62 | $0.58 | 26,322 | 06-07-2024 |
$0.5936 | $0.561 | $0.5936 | $0.625001 | $0.561 | 9,658 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Forte Biosciences Inc. Company Name:
FBRX Stock Symbol:
NASDAQ Market:
Forte Biosciences Inc. Website:
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced first quarter 2024 results and provided a business update. First Quarter 2024 Business Highlights ȁ...
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its 2023 results and provided a business update. 2023 Business Highlights “Forte achieved a major...